NCT07192341
- Conditions
- Cardiovascular Diseases, Heart Diseases, Heart Failure, +3 more
- Locations
-
- Kafrelsheikh University Kafr ash Shaykh, Kafrelsheikh, Egypt
Clinical trial condition
Sacubitril/Valsartan
Explore clinical trials studying Sacubitril/Valsartan. Study availability and eligibility vary by location and protocol.
5 public trials
3 recruiting studies
Sacubitril/Valsartan trial results
NCT05465031
- Conditions
- Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Antihypertensive Agents, +24 more
- Locations
-
- Regional Cancer Centre in Opole Opole, Opole Voivodeship, Poland
- Maria Sklodowska-Curie Institute - Oncology Centre (MSCI), Gliwice Branch Gliwice, Silesian Voivodeship, Poland
- Silesian Center for Heart Diseases Zabrze, Silesian Voivodeship, Poland
- Holy Cross Cancer Centre, Cardio-Oncology Division Kielce, Świętokrzyskie Voivodeship, Poland
NCT05498675
- Conditions
- Body Weight, Cardiovascular Diseases, Hypertension, +9 more
- Locations
-
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
Not Yet Recruiting
Evaluating Dashboard-Integrated Pharmacist-Led Education on Improving Sacubitril/Valsartan Adherence in Heart Failure (PharmD ASSIST HFrEF)
NCT06900803
- Conditions
- Behavior, Health Behavior, Heart Failure With Reduced Ejection Fraction (HFrEF), +5 more
- Locations
-
Not specified
Completed
The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF
NCT07417215
- Conditions
- Heart Failure With Preserved Ejection Fraction (HFpEF), Hemodialysis, Sacubitril/Valsartan
- Locations
-
- University Clinical Hospital Mostar Mostar, Bosnia and Herzegovina